跳至主要内容
临床试验/CTRI/2019/01/017047
CTRI/2019/01/017047尚未招募3 期

Comparative clinical study on kshar of Swertia chirayata roxb. Flem. and Swertia angustifolia buch-ham.Exd.Don,processed in mahish mootra w.s.r.to agnideepan activity.

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
Improvement in subjective and objective parameters.

研究概览

简要总结

Ayurveda views the health of an individual as the proper functioning of Agni(digestive fire inside body). Agnimandhya is the pathological state of inhibited agni.As per Acharya Baghbhat Agnimandhya leads to manifestation of all types of diseases. Kshar is prescribed to cure Agnimandhya . Acharya Charak has described Bhunimbadi kshar to cure Agnimandhya. In this study kshar of two species of chiraita (bhunimb) i. e Swertia chirayata and Swertia angustifolia  are taken. The study aims to compare the effectiveness of both drugs.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients having classical signs and symptoms of jatharagnimandhya like Avipaka, Chardi, Angamard, Udara Gaurav, Ksudhanasa, Mukha durgandha, etc will be selected.
  • 2.Patients of either sex with age group between 20 to 70 years will be selected.

排除标准

  • Patients with chronic disease like severe Hypertension, IHD, COPD, DM, cancer, Hepatic and renal insufficiency, psychotic disorders like depression, schizophrenia.
  • 2.Any acute illness /serious illness.
  • 3.Pregnant women and lactating mothers.

结局指标

主要结局

Improvement in subjective and objective parameters.

时间窗: 21days

次要结局

  • To find comparative efficacy of either treatment.(21 days)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验